Open Cross Over Randomized Clinical Trial to Evaluate Tolerability and Pharmacodynamic Profile of Metformin Glycinate 620 mg, Metformin Glycinate 1240 mg, Metformin Glycinate 2480 mg and Metformin Chlorhydrate 1000 mg After Administration of One Single Dose, Multiple Dose and Intake of Food in Healthy Volunteers

Trial Profile

Open Cross Over Randomized Clinical Trial to Evaluate Tolerability and Pharmacodynamic Profile of Metformin Glycinate 620 mg, Metformin Glycinate 1240 mg, Metformin Glycinate 2480 mg and Metformin Chlorhydrate 1000 mg After Administration of One Single Dose, Multiple Dose and Intake of Food in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2014

At a glance

  • Drugs Metformin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Laboratorios Silanes
  • Most Recent Events

    • 13 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 27 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top